How OpenEvidence Is Winning Over Skeptical Clinicians With AI That Fits the Room
Modern Healthcare examines how OpenEvidence’s chief medical officer is persuading skeptical clinicians to adopt AI. The key appears to be clinical credibility, workflow awareness, and a product approach that respects medical judgment rather than trying to replace it.
The OpenEvidence story is important because it focuses on a problem many AI companies underestimate: clinician skepticism is not just about accuracy, but about fit. Doctors want tools that understand how they work, not systems that ask them to reorganize everything around software.
That is why leadership matters. A chief medical officer can translate between the language of product design and the language of clinical practice, helping a company avoid the common mistake of marketing AI as magical rather than practical.
This also reflects a broader maturation of the market. The next generation of health AI vendors may win not by claiming superior intelligence, but by proving they can be useful in a specialty-specific workflow and win over experts who are trained to be cautious.
If OpenEvidence is making progress, it suggests the adoption curve is less about hype and more about trust architecture: governance, evidence, usability, and clinician-facing credibility. Those are harder to build than a model demo, but they are what determine whether a product survives procurement.